Krystal Biotech Inc (KRYS) P/E ratio is 46.14
Krystal Biotech Inc (KRYS) P/E ratio is 46.14 as of 2026-06-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full KRYS research page for quote, filings, and the rest of the model. This satellite exists so “Krystal Biotech Inc P/E ratio” can rank with the actual number, then send you to /stock/krys.